We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
1 Year Est. Return
+114.45%
AUM
$1.12B
AUM Growth
-$192M
(-15%)
Holding
40
Top Buys
| 1 | +$28.3M | |
| 2 | +$24.8M | |
| 3 | +$22.2M | |
| 4 |
Apogee Therapeutics
APGE
|
+$21.2M |
| 5 |
Omnicell
OMCL
|
+$20.5M |
Top Sells
| 1 | +$41.5M | |
| 2 | +$40M | |
| 3 | +$38.9M | |
| 4 |
Vera Therapeutics
VERA
|
+$23.9M |
| 5 |
Rhythm Pharmaceuticals
RYTM
|
+$20.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
GeneDx Holdings
WGS
$1.67B
| $15.6M | 1.4% |
+242,927
|
|
||
27
Wave Life Sciences
WVE
$1.11B
| $13.4M | 1.2% |
1,843,968
-9,883
|
|
||
|
28
Vera Therapeutics
VERA
$2.28B
| $12.6M | 1.13% |
313,906
-555,770
|
|
||
29
MiMedx Group
MDXG
$553M
| $11.2M | 1.01% |
2,842,892
-196,449
|
|
||
30
Butterfly Network
BFLY
$1.34B
| $10.7M | 0.96% |
2,660,167
-151,964
|
|
||
|
SGP
31
SpyGlass Pharma
SGP
$608M
| $9.72M | 0.87% |
+375,000
|
|
||
32
Organogenesis Holdings
ORGO
$319M
| $8.29M | 0.74% |
3,498,533
-364,287
|
|
||
33
Vaxcyte
PCVX
$6.77B
| $8.24M | 0.74% |
+141,784
|
|
||
34
Enliven Therapeutics
ELVN
$2.2B
| $7.91M | 0.71% |
+201,867
|
|
||
|
35
Rhythm Pharmaceuticals
RYTM
$6.03B
| $7.58M | 0.68% |
87,181
-208,663
|
|
||
|
ABVX
36
Abivax
ABVX
$8.19B
| – | – |
-88,674
|
|
||
37
Dyne Therapeutics
DYN
$2.96B
| – | – |
-155,231
|
|
||
38
Disc Medicine
IRON
$2.61B
| – | – |
-523,167
|
|
||
39
iShares Russell 2000 Growth ETF
IWO
$14.3B
| – | – |
-760
|
|
||
40
Madrigal Pharmaceuticals
MDGL
$11B
| – | – |
-66,831
|
|